A citation-based method for searching scientific literature

Ziyi Bai, Yao Zhou, Zifan Ye, Jialong Xiong, Hongying Lan, Feng Wang. Front Immunol 2022
Times Cited: 5







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS.
Esko A Kautto, Russell Bonneville, Jharna Miya, Lianbo Yu, Melanie A Krook, Julie W Reeser, Sameek Roychowdhury. Oncotarget 2017
132
40

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.
G J Freeman, A J Long, Y Iwai, K Bourque, T Chernova, H Nishimura, L J Fitz, N Malenkovich, T Okazaki, M C Byrne,[...]. J Exp Med 2000
20


Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity.
Fumiya Hirano, Katsumi Kaneko, Hideto Tamura, Haidong Dong, Shengdian Wang, Masao Ichikawa, Cecilia Rietz, Dallas B Flies, Julie S Lau, Gefeng Zhu,[...]. Cancer Res 2005
704
20

Crystal structure of PD-1 in complex with an antibody-drug tislelizumab used in tumor immune checkpoint therapy.
Sang Hyung Lee, Hyun Tae Lee, Heejin Lim, Yujin Kim, Ui Beom Park, Yong-Seok Heo. Biochem Biophys Res Commun 2020
5
20

PHENIX: a comprehensive Python-based system for macromolecular structure solution.
Paul D Adams, Pavel V Afonine, Gábor Bunkóczi, Vincent B Chen, Ian W Davis, Nathaniel Echols, Jeffrey J Headd, Li-Wei Hung, Gary J Kapral, Ralf W Grosse-Kunstleve,[...]. Acta Crystallogr D Biol Crystallogr 2010
20

The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors.
David Yin-Wei Lin, Yoshimasa Tanaka, Masashi Iwasaki, Apostolos G Gittis, Hua-Poo Su, Bunzo Mikami, Taku Okazaki, Tasuku Honjo, Nagahiro Minato, David N Garboczi. Proc Natl Acad Sci U S A 2008
247
20

PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
Y Latchman, C R Wood, T Chernova, D Chaudhary, M Borde, I Chernova, Y Iwai, A J Long, J A Brown, R Nunes,[...]. Nat Immunol 2001
20

Molecular replacement with MOLREP.
Alexei Vagin, Alexei Teplyakov. Acta Crystallogr D Biol Crystallogr 2010
20

Antibodies to watch in 2022.
Hélène Kaplon, Alicia Chenoweth, Silvia Crescioli, Janice M Reichert. MAbs 2022
20
20

Sweet Immune Checkpoint Targets to Enhance T Cell Therapy.
Nohelly Derosiers, William Aguilar, David A DeGaramo, Avery D Posey. J Immunol 2022
5
20

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.
Tyler J Curiel, Shuang Wei, Haidong Dong, Xavier Alvarez, Pui Cheng, Peter Mottram, Roman Krzysiek, Keith L Knutson, Ben Daniel, Maria Carla Zimmermann,[...]. Nat Med 2003
915
20

Dostarlimab: First Approval.
Anthony Markham. Drugs 2021
14
20

Preclinical characterization of dostarlimab, a therapeutic anti-PD-1 antibody with potent activity to enhance immune function in in vitro cellular assays and in vivo animal models.
Sujatha Kumar, Srimoyee Ghosh, Geeta Sharma, Zebin Wang, Marilyn R Kehry, Margaret H Marino, Tamlyn Y Neben, Sharon Lu, Shouqi Luo, Simon Roberts,[...]. MAbs 2021
4
25

Pembrolizumab for the treatment of non-small-cell lung cancer.
Edward B Garon, Naiyer A Rizvi, Rina Hui, Natasha Leighl, Ani S Balmanoukian, Joseph Paul Eder, Amita Patnaik, Charu Aggarwal, Matthew Gubens, Leora Horn,[...]. N Engl J Med 2015
20

Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy.
Ju Yeon Lee, Hyun Tae Lee, Woori Shin, Jongseok Chae, Jaemo Choi, Sung Hyun Kim, Heejin Lim, Tae Won Heo, Kyeong Young Park, Yeon Ji Lee,[...]. Nat Commun 2016
133
20

Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups.
Lawrence P Andrews, Hiroshi Yano, Dario A A Vignali. Nat Immunol 2019
172
20

Features and development of Coot.
P Emsley, B Lohkamp, W G Scott, K Cowtan. Acta Crystallogr D Biol Crystallogr 2010
20

XDS.
Wolfgang Kabsch. Acta Crystallogr D Biol Crystallogr 2010
20

FDA approves 100th monoclonal antibody product.
Asher Mullard. Nat Rev Drug Discov 2021
78
20

Cemiplimab: First Global Approval.
Anthony Markham, Sean Duggan. Drugs 2018
79
20

The Role of Immune Checkpoint Blockade in the Hepatocellular Carcinoma: A Review of Clinical Trials.
Muhammet Ozer, Andrew George, Suleyman Yasin Goksu, Thomas J George, Ilyas Sahin. Front Oncol 2021
3
33

Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response.
Rajarsi Mandal, Robert M Samstein, Ken-Wing Lee, Jonathan J Havel, Hao Wang, Chirag Krishna, Erich Y Sabio, Vladimir Makarov, Fengshen Kuo, Pedro Blecua,[...]. Science 2019
230
20

The context-specific role of germline pathogenicity in tumorigenesis.
Preethi Srinivasan, Chaitanya Bandlamudi, Philip Jonsson, Yelena Kemel, Shweta S Chavan, Allison L Richards, Alexander V Penson, Craig M Bielski, Christopher Fong, Aijazuddin Syed,[...]. Nat Genet 2021
9
20

Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel.
Jinru Shia, Laura H Tang, Efsevia Vakiani, Jose G Guillem, Zsofia K Stadler, Robert A Soslow, Nora Katabi, Martin R Weiser, Philip B Paty, Larissa K Temple,[...]. Am J Surg Pathol 2009
123
20

MSIseq: Software for Assessing Microsatellite Instability from Catalogs of Somatic Mutations.
Mi Ni Huang, John R McPherson, Ioana Cutcutache, Bin Tean Teh, Patrick Tan, Steven G Rozen. Sci Rep 2015
76
20

HSP110 T17 simplifies and improves the microsatellite instability testing in patients with colorectal cancer.
Olivier Buhard, Anaïs Lagrange, Agathe Guilloux, Chrystelle Colas, Mouna Chouchène, Kristell Wanherdrick, Florence Coulet, Erell Guillerm, Coralie Dorard, Laetitia Marisa,[...]. J Med Genet 2016
33
20

Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation.
Aoife J McCarthy, Jose-Mario Capo-Chichi, Tara Spence, Sylvie Grenier, Tracy Stockley, Suzanne Kamel-Reid, Stefano Serra, Peter Sabatini, Runjan Chetty. J Pathol Clin Res 2019
44
20

Heterogeneity of mismatch repair defect in colorectal cancer and its implications in clinical practice.
Gaelle Tachon, Eric Frouin, Lucie Karayan-Tapon, Marie-Luce Auriault, Julie Godet, Valerie Moulin, Qing Wang, David Tougeron. Eur J Cancer 2018
18
20

MSIsensor: microsatellite instability detection using paired tumor-normal sequence data.
Beifang Niu, Kai Ye, Qunyuan Zhang, Charles Lu, Mingchao Xie, Michael D McLellan, Michael C Wendl, Li Ding. Bioinformatics 2014
349
20


Unexpected expression of mismatch repair protein is more commonly seen with pathogenic missense than with other mutations in Lynch syndrome.
Wei Chen, Heather Hampel, Rachel Pearlman, Dan Jones, Weiqiang Zhao, Mohammed Alsomali, Deborah Knight, Wendy L Frankel. Hum Pathol 2020
5
20

MSIsensor-ct: microsatellite instability detection using cfDNA sequencing data.
Xinyin Han, Shuying Zhang, Daniel Cui Zhou, Dongliang Wang, Xiaoyu He, Danyang Yuan, Ruilin Li, Jiayin He, Xiaohong Duan, Michael C Wendl,[...]. Brief Bioinform 2021
7
20


MSIsensor-pro: Fast, Accurate, and Matched-normal-sample-free Detection of Microsatellite Instability.
Peng Jia, Xiaofei Yang, Li Guo, Bowen Liu, Jiadong Lin, Hao Liang, Jianyong Sun, Chengsheng Zhang, Kai Ye. Genomics Proteomics Bioinformatics 2020
17
20


JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.
T Yoshino, G Pentheroudakis, S Mishima, M J Overman, K-H Yeh, E Baba, Y Naito, F Calvo, A Saxena, L-T Chen,[...]. Ann Oncol 2020
38
20

High throughput detection of microsatellite instability by denaturing high-performance liquid chromatography.
Kai-feng Pan, Wanguo Liu, You-Yong Lu, Lian Zhang, Zhen-pu Li, Wan-Li Lu, Stephen N Thibodeau, Wei-Cheng You. Hum Mutat 2003
22
20

Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature.
Yevgeniy Karamurzin, Zhaoshi Zeng, Zsofia K Stadler, Liying Zhang, Ihsane Ouansafi, Hikmat A Al-Ahmadie, Christine Sempoux, Leonard B Saltz, Robert A Soslow, Eileen M O'Reilly,[...]. Hum Pathol 2012
72
20

Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers.
Pauline Gilson, Julien Levy, Marie Rouyer, Jessica Demange, Marie Husson, Céline Bonnet, Julia Salleron, Agnès Leroux, Jean-Louis Merlin, Alexandre Harlé. Sci Rep 2020
16
20

Cytoplasmic MSH2 immunoreactivity in a patient with Lynch syndrome with an EPCAM-MSH2 fusion.
Shigeki Sekine, Reiko Ogawa, Shinya Saito, Mineko Ushiama, Dai Shida, Takeshi Nakajima, Hirokazu Taniguchi, Nobuyoshi Hiraoka, Teruhiko Yoshida, Kokichi Sugano. Histopathology 2017
12
20

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.
Glenn E Palomaki, Monica R McClain, Stephanie Melillo, Heather L Hampel, Stephen N Thibodeau. Genet Med 2009
343
20

A TGF betaRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells.
I Saeterdal, M K Gjertsen, P Straten, J A Eriksen, G Gaudernack. Cancer Immunol Immunother 2001
61
20

Endometrial and colorectal tumors from patients with hereditary nonpolyposis colon cancer display different patterns of microsatellite instability.
Shannon A Kuismanen, Anu-Liisa Moisio, Pascal Schweizer, Kaspar Truninger, Reijo Salovaara, Johanna Arola, Ralf Butzow, Josef Jiricny, Minna Nyström-Lahti, Päivi Peltomäki. Am J Pathol 2002
88
20

Microsatellite instability detection by next generation sequencing.
Stephen J Salipante, Sheena M Scroggins, Heather L Hampel, Emily H Turner, Colin C Pritchard. Clin Chem 2014
224
20

The somatic mutation frequency of the transforming growth factor beta receptor type II gene varies widely among different cancers with microsatellite instability.
T Abe, H Ouyang, T Migita, Y Kato, M Kimura, K Shiiba, M Sunamura, S Matsuno, A Horii. Eur J Surg Oncol 1996
46
20

Identification of cancer patients with Lynch syndrome: clinically significant discordances and problems in tissue-based mismatch repair testing.
Angela N Bartley, Rajyalakshmi Luthra, Devki S Saraiya, Diana L Urbauer, Russell R Broaddus. Cancer Prev Res (Phila) 2012
86
20

Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologies.
Monika Vyas, Canan Firat, Jaclyn F Hechtman, Martin R Weiser, Rona Yaeger, Chad Vanderbilt, Jamal K Benhamida, Ajaratu Keshinro, Liying Zhang, Peter Ntiamoah,[...]. Fam Cancer 2021
4
25


The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker.
Denis L Jardim, Aaron Goodman, Debora de Melo Gagliato, Razelle Kurzrock. Cancer Cell 2021
86
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.